CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- 4 Planned sale Director sold 7,900 shares at $90.32 ($713,493)
- 144 Insider Sale of Securities
- 4 Planned sale President, R&D sold 50,000 shares at an average $87.65 ($4,382,424)
- 4 Planned sale President and CEO sold 50,000 shares at an average $87.65 ($4,382,424)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3ASR Offering Registration Statement
- 4 Derivatives Options or other derivatives
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- UPLOAD Other SEC-generated Letter
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Director sold 40,000 shares at $83.25 ($3,329,972)
- 4 Derivatives Options or other derivatives
Page 12 of 26 · 513 filings